Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lingl, F.A.
1973.
Double-Blind comparison of haloperidol and thioridazine in treatment resistant psychoneurotic outpatients.
Psychosomatics,
Vol. 14,
Issue. 4,
p.
235.
LORD, D. J.
and
KIDD, C. B.
1973.
HALOPERIDOL VERSUS DIAZEPAM: A DOUBLE—BLIND CROSSOVER CLINICAL TRIAL.
Medical Journal of Australia,
Vol. 1,
Issue. 12,
p.
586.
JANSSEN, PAUL A.J.
1974.
Psychopharmacological Agents.
p.
129.
Beck-Friis, Johan
Fyrö, Bengt
and
Sjöstrand, Inga-Greta
1974.
En Jämförelse Mellan Diazepam Och Haloperidol Vid Neurotiska Ångest-Och Spänningstillstånd Hos Patienter I Öppen Vård.
Nordisk Psykiatrisk Tidsskrift,
Vol. 28,
Issue. 6,
p.
465.
Fyrö, B.
Beck‐Friis, J.
and
Sjöstrand, I.‐G.
1974.
A COMPARISON BETWEEN DIAZEPAM AND HALOPERIDOL IN ANXIETY STATES.
Acta Psychiatrica Scandinavica,
Vol. 50,
Issue. 6,
p.
586.
Molander, Lars
and
Duvhök, Christina
1976.
Acute Effects of Oxazepam, Diazepam and Methylperone, alone and in Combination with Alcohol on Sedation, Coordination and Mood.
Acta Pharmacologica et Toxicologica,
Vol. 38,
Issue. 2,
p.
145.
Boutin, Roger
1979.
Psychoactive drugs: Effective use of low doses.
Psychosomatics,
Vol. 20,
Issue. 6,
p.
403.
Budden, M. G.
1979.
A comparative study of haloperidol and diazepam in the treatment of anxiety.
Current Medical Research and Opinion,
Vol. 5,
Issue. 10,
p.
759.
Molander, Lars
1982.
Effect of melperone, chlorpromazine, haloperidol, and diazepam on experimental anxiety in normal subjects.
Psychopharmacology,
Vol. 77,
Issue. 2,
p.
109.
Bruhwyler, J.
Chleide, E.
and
Mercier, M.
1990.
Effects of low doses of neuroleptics on temporal regulation in a differential reinforcement of response duration (DRRD) schedule in the dog.
Pharmacology Biochemistry and Behavior,
Vol. 37,
Issue. 4,
p.
607.
Bruhwyler, J.
Chleide, E.
Liégeois, J-F.
Delarge, J.
and
Mercier, M.
1990.
Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test.
Pharmacology Biochemistry and Behavior,
Vol. 36,
Issue. 1,
p.
57.
Bruhwyler, J.
Chleide, E.
Liégeois, J-F.
Delarge, J.
and
Mercier, M.
1991.
Effects of specific dopaminergic agonists and antagonists in the open-field test.
Pharmacology Biochemistry and Behavior,
Vol. 39,
Issue. 2,
p.
367.
Megens, Anton A. H. P.
Niemegeers, Carlos J. E.
and
Awouters, Frans H. L.
1992.
Antipsychotic profile and side‐effect liability of haloperidol, risperidone, and ocaperidone as predicted from their differential interaction with amphetamine in rats.
Drug Development Research,
Vol. 26,
Issue. 2,
p.
129.
Megens, A. A. H. P.
Awouters, F. H. L.
Schotte, A.
Meert, T. F.
Dugovic, C.
Niemegeers, C. J. E.
and
Leysen, J. E.
1994.
Survey on the pharmacodynamics of the new antipsychotic risperidone.
Psychopharmacology,
Vol. 114,
Issue. 1,
p.
9.
Wurthmann, C.
2000.
Leitlinien zur Diagnostik und Therapie von Angsterkrankungen.
p.
85.
eLetters
No eLetters have been published for this article.